October 2009 - Volume 52 - Issue 2 - Contributor Index

Alphabetical Search
B
Q
U
X
Y
Z
Author:
Back, David PhD

Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers

Boffito, Marta; Jackson, Akil; Lamorde, Mohammed; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):222-227, October 2009.

Evaluation of Adherence and Factors Affecting Adherence to Combination Antiretroviral Therapy Among White, Hispanic, and Black Men in the MACS Cohort

Oh, Debora Lee; Sarafian, Farjad; Silvestre, Anthony; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):290-293, October 2009.

Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

Kigozi, Isaac M; Dobkin, Loren M; Martin, Jeffrey N; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):280-289, October 2009.

Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers

Boffito, Marta; Jackson, Akil; Lamorde, Mohammed; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):222-227, October 2009.

The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma

Aissani, Brahim; Ogwaro, Kisani M; Shrestha, Sadeep; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):170-179, October 2009.

Evaluation of Adherence and Factors Affecting Adherence to Combination Antiretroviral Therapy Among White, Hispanic, and Black Men in the MACS Cohort

Oh, Debora Lee; Sarafian, Farjad; Silvestre, Anthony; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):290-293, October 2009.

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations

van Luin, Matthijs; Gras, Luuk; Richter, Clemens; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(2):240-245, October 2009.